- Semi-Solid Formulations
- Liquid Formulations
- Solid Formulations
- Transdermal Products
The Topical Drug Delivery Market Size was valued at USD 317.8 billion in 2023 and is poised to grow at a significant CAGR of 9.3% over 2024-2030. Topical Drug Delivery medication delivery is known to be one of the most effective methods of drug delivery owing to its finest therapeutic benefits. The rising incidences of skin disease and related issues globally are the factors that contribute to the topical drug delivery market growth. Furthermore, increasing benefits of transdermal medicine such as low rejection rate, excellent ease of administration, and outstanding patient convenience and persistence, over oral and ingesting medications (medications for gastrointestinal toxicity) that result in nausea and vomiting, are pushing the demand for the topical drug delivery market. Additionally, due to its non-invasive nature, patches decreased the inconvenience brought on by parenteral or intravenous therapies is propelling the market growth. During covid 19, the topical drug delivery market is hit badly by lockdowns worldwide. That pandemic also hurt the supply and demand chain of raw materials needed to make medications (such as drugs and manufacturing equipment). On the brighter side, the global economy is projected to gradually normalize, with an increase in the manufacturing and transportation of raw materials and associated equipment, resulting in market growth.
Topical Drug Delivery Market Key Developments:
- In Nov 2021, Nexgel launched MEDAGEL Migraine Relief Patch. The patches draw heat away from the body using Nexgel's proprietary hydrogel technology and provide immediate and long-lasting cooling relief from migraines, fevers, and hormonal headaches.
- In June 2021, Luye Pharma Group launched the Rivastigmine Transdermal Patch in China for the treatment of mild to moderate Alzheimer's disease.
Topical Drug Delivery Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
9.3%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Topical Drug Delivery Market Dynamics
People are more likely to develop skin infections such as eczema, psoriasis, and minor ailments including acne these are the key drivers for the topical drug delivery market. Furthermore, the growing incidences of burn injuries, the prevalence of diabetes and eye diseases, and the wide use of drugs to treat diabetic neuropathic pain and foot ulcers are also projected to have a progressive growth rate in the global market. Technical barriers associated with skin irritation and permeability are expected to challenge the topical drug delivery market in the forecast period. The topical drug delivery market is hindered by the presence of various alternative drug delivery modes for patients.
North-America Got Significant Share
Topical Drug Delivery Market Regional Analysis
North America is expected to dominate the topical drug delivery market over the forecasted period attributed to the factors such as the growing incidence of skin diseases and related issues, rising healthcare expenditures, and growing key players in this region. Day by day skin diseases is increasing among a part of the population globally. For instance, according to GLOBOCAN 2020 fact sheet, about 105,000 new cases of melanoma skin cancer were reported in the North American region, and this number is anticipated to reach 142,000 by the year 2040. Furthermore, as per the 2022 statistics report of the American Academy of Dermatology Association, in the United States, acne is the most prevalent skin disorder, affecting up to 50 million people each year. Thus, the increasing number of cases of skin disease is expected to boost the demand for effective topical treatments and consequently is projected to the expansion of the topical drug delivery market over the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
Topical Drug Delivery Market Segmentation
By Product Type
By Distribution Channel
- Retail
- Direct Tenders
By End User
- Clinics
- Hospitals
- Home Healthcare
- Diagnostic Centers
- Others
Frequently Asked Questions
Applying medication to the skin or mucous membranes allows it to enter the body from there. Medication applied in this way is known as a topical medication. It can also be used to treat pain or other diseases in specific parts of the body.
Transdermal products are administered to the skin and the drugs permeate into the systemic circulation and are sent throughout the body to the targeted section
Rising skin infections such as eczema, psoriasis, and minor ailments including acne and research and development in the healthcare infrastructure.
Key Features of the Reports
- The topical drug delivery market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights into the competitor's overview, company share analysis, key market developments, and key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and startup details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
- The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter Five Force Analysis in addition to recent technology advancements and innovations in the market
| 1. Executive Summary |
| 2. Global Topical Drug Delivery Market Introduction |
| 2.1. Global Topical Drug Delivery Market - Taxonomy |
| 2.2. Global Topical Drug Delivery Market -Definitions |
| 2.2.1. Product Type |
| 2.2.2. Route Of Administration |
| 2.2.3. Distribution channel |
| 2.2.4. End User |
| 2.2.5. Geography |
| 3. Global Topical Drug Delivery Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Topical Drug Delivery Market Dynamic Factors - Impact Analysis |
| 3.6. Global Topical Drug Delivery Market - Competition Landscape |
| 4. Global Topical Drug Delivery Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Topical Drug Delivery Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Semi-Solids Formulations |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Liquid Formulations |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Solids Formulations |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Transdermal Products |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Topical Drug Delivery Market, By Route Of Administration, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1. Dermal Drug Delivery |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ophthalmic Drug Delivery |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Rectal Drug Delivery |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Vaginal Drug Delivery |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Nasal Drug Delivery |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Topical Drug Delivery Market Forecast, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. Retail |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Direct Tenders |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Topical Drug Delivery Market Forecast, By End User, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. Clinics |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Hospitals |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Home Healthcare |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Diagnostics Centre’s |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Others |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Global Topical Drug Delivery Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
| 10. North America Topical Drug Delivery market analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Semi-Solid Formulations |
| 10.1.2. Liquid Formulations |
| 10.1.3. Solid Formulations |
| 10.1.4. Transdermal Products |
| 10.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Dermal Drug Delivery |
| 10.2.2. Ophthalmic Drug Delivery |
| 10.2.3. Rectal Drug Delivery |
| 10.2.4. Vaginal Drug Delivery |
| 10.2.5. Nasal Drug Delivery |
| 10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Retail |
| 10.3.2. Direct Tenders |
| 10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Clinics |
| 10.4.2. Hospitals |
| 10.4.3. Home Healthcare |
| 10.4.4. Diagnostic Centers |
| 10.4.5. Others |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
| 10.7. North America Topical Drug Delivery Market Dynamics - Trends |
| 11. Europe Topical Drug Delivery Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Semi-Solid Formulations |
| 11.1.2. Liquid Formulations |
| 11.1.3. Solid Formulations |
| 11.1.4. Transdermal Products |
| 11.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Dermal Drug Delivery |
| 11.2.2. Ophthalmic Drug Delivery |
| 11.2.3. Rectal Drug Delivery |
| 11.2.4. Vaginal Drug Delivery |
| 11.2.5. Nasal Drug Delivery |
| 11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Retail |
| 11.3.2. Direct Tenders |
| 11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Clinics |
| 11.4.2. Hospitals |
| 11.4.3. Home Healthcare |
| 11.4.4. Diagnostic Centers |
| 11.4.5. Others |
| 11.5. Country Analysis 2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Poland |
| 11.5.8. Rest of Europe |
| 11.6. Europe Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
| 11.7. Europe Topical Drug Delivery Market Dynamics - Trends |
| 12. Asia-Pacific Topical Drug Delivery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Semi-Solid Formulations |
| 12.1.2. Liquid Formulations |
| 12.1.3. Solid Formulations |
| 12.1.4. Transdermal Products |
| 12.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Dermal Drug Delivery |
| 12.2.2. Ophthalmic Drug Delivery |
| 12.2.3. Rectal Drug Delivery |
| 12.2.4. Vaginal Drug Delivery |
| 12.2.5. Nasal Drug Delivery |
| 12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Retail |
| 12.3.2. Direct Tenders |
| 12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Clinics |
| 12.4.2. Hospitals |
| 12.4.3. Home Healthcare |
| 12.4.4. Diagnostic Centers |
| 12.4.5. Others |
| 12.5. Country Analysis2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. Japan |
| 12.5.2. China |
| 12.5.3. India |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
| 12.7. Asia-Pacific Topical Drug Delivery Market Dynamics - Trends |
| 13. Latin America Topical Drug Delivery Market Analysis,2019 - 2023 and Forecast, 2022-2028(Revenue, USD Mn) |
| 13.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Semi-Solid Formulations |
| 13.1.2. Liquid Formulations |
| 13.1.3. Solid Formulations |
| 13.1.4. Transdermal Products |
| 13.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Dermal Drug Delivery |
| 13.2.2. Ophthalmic Drug Delivery |
| 13.2.3. Rectal Drug Delivery |
| 13.2.4. Vaginal Drug Delivery |
| 13.2.5. Nasal Drug Delivery |
| 13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Retail |
| 13.3.2. Direct Tenders |
| 13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Clinics |
| 13.4.2. Hospitals |
| 13.4.3. Home Healthcare |
| 13.4.4. Diagnostic Centers |
| 13.4.5. Others |
| 13.5. Country Analysis 2017-2021and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Argentina |
| 13.5.4. Rest of Latin America |
| 13.6. Latin America Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
| 13.7. Latin America Topical Drug Delivery Market Dynamics - Trends |
| 14. Middle East and Africa Topical Drug Delivery Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 14.1. Product Type Analysis 2017-2021and Forecast 2024 - 2030by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Semi-Solid Formulations |
| 14.1.2. Liquid Formulations |
| 14.1.3. Solid Formulations |
| 14.1.4. Transdermal Products |
| 14.2. Route Of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.2.1. Dermal Drug Delivery |
| 14.2.2. Ophthalmic Drug Delivery |
| 14.2.3. Rectal Drug Delivery |
| 14.2.4. Vaginal Drug Delivery |
| 14.2.5. Nasal Drug Delivery |
| 14.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Retail |
| 14.3.2. Direct Tenders |
| 14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Clinics |
| 14.4.2. Hospitals |
| 14.4.3. Home Healthcare |
| 14.4.4. Diagnostic Centers |
| 14.4.5. Others |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. Israel |
| 14.5.3. South Africa |
| 14.5.4. Rest of MEA |
| 14.6. MEA Topical Drug Delivery Market - Opportunity Analysis Index, By Product Type, Route Of Administration, Distribution Channel, End User, and Region, 2024 - 2030 |
| 14.7. MEA Topical Drug Delivery Market Dynamics - Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Johnson & Johnson Private Limited (U.S.) |
| 15.2.2. Allergan (Ireland) |
| 15.2.3. Nestlé India Ltd., (Switzerland) |
| 15.2.4. Merck & Co Inc., (U.S.) |
| 15.2.5. Novartis AG (Switzerland) |
| 15.2.6. GlaxoSmithKline plc (U.K) |
| 15.2.7. Bausch Health Companies Inc., (Canada) |
| 15.2.8. Bayer AG (Germany), |
| 15.2.9. Crescita Therapeutics (Canada) |
| 15.2.10. LEO Pharma A/S (Denmark) |
| 15.2.11. Hisamitsu Pharmaceutical Co., Inc. (Japan) |
| 15.2.12. Glenmark Pharmaceuticals Limited, (India) |
| 15.2.13. Cipla Inc., (India) |
| 15.2.14. Mylan N.V. (U.S.) |
| 15.2.15. Encore Dermatology, (U.S.) |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Johnson & Johnson Private Limited
- Allergan
- Nestle India Ltd.
- Merck & Co Inc.
- Novartis AG
- GlaxoSmithKline plc
- Bausch Health Companies Inc.
- Bayer AG
- Crescita Therapeutics
- LEO Pharma A/S
- Hisamitsu Pharmaceutical Co., Inc.
- Glenmark Pharmaceuticals Limited
- Cipla Inc.,
- Mylan N.V.
- Encore Dermatology